Jill Murphy, Assistant Editor

Articles by Jill Murphy, Assistant Editor

Two large studies demonstrating patient-reported outcomes showed that quality of life was maintained longer with newer drug combinations compared with standard of care for the treatment of patients with a specific type of colorectal cancer (CRC) and unresectable hepatocellular carcinoma (HCC). The results were presented at the 2020 Gastrointestinal Cancers Symposium in San Francisco, California, from January 23-25.

According to a survey commissioned by the American Academy of Family Physicians, certain groups, including millennials and African Americans, are more susceptible to anti-vaccination rhetoric and beliefs, with 51% of Americans reporting they have not received a flu shot this season. In addition, nearly one-third of adults who completed the survey do not plan on getting a flu shot.

There is a statistically significant difference in the number of patients that meet statin criteria for primary prevention, and those that were prescribed it in a Federally Qualified Health Center (FQHC), according to student research presented at the ASHP (American Society of Health-System Pharmacists) 54th Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.